GIM
Granahan Investment Management Portfolio holdings
AUM
$2.46B
This Quarter Return
+6.03%
1 Year Return
+66.36%
3 Year Return
+183.04%
5 Year Return
+309.49%
10 Year Return
+1,968.52%
AUM
$3.27B
AUM Growth
+$208M
(+6.8%)
Cap. Flow
+$152M
Cap. Flow
% of AUM
4.64%
Top 10 Holdings %
Top 10 Hldgs %
30.91%
Holding
183
New
7
Increased
120
Reduced
43
Closed
13
Top Buys
| 1 |
RB Global
RBA
|
$30.7M |
| 2 |
Azenta
AZTA
|
$23.9M |
| 3 |
Evolent Health
EVH
|
$19.7M |
| 4 |
HubSpot
HUBS
|
$17.1M |
| 5 |
Sprout Social
SPT
|
$16.9M |
Top Sells
| 1 |
Axon Enterprise
AXON
|
$32.2M |
| 2 |
Kulicke & Soffa
KLIC
|
$20.5M |
| 3 |
Enphase Energy
ENPH
|
$15.9M |
| 4 |
CoStar Group
CSGP
|
$11.2M |
| 5 |
Life Time Group Holdings
LTH
|
$10.8M |
Sector Composition
| 1 | Technology | 41.43% |
| 2 | Healthcare | 20.31% |
| 3 | Industrials | 13.2% |
| 4 | Consumer Discretionary | 8.69% |
| 5 | Communication Services | 6.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Clean Energy Fuels
CLNE
$548M
| $8.53M | 0.26% |
1,640,831
+177,103
| +12% | +$921K |
|
102
Arcus Biosciences
RCUS
$1.24B
| $8.49M | 0.26% |
410,480
+67,145
| +20% | +$1.39M |
|
103
908 Devices
MASS
$214M
| $8.42M | 0.26% |
1,104,904
+137,540
| +14% | +$1.05M |
|
104
Vicor
VICR
$2.27B
| $8.26M | 0.25% |
153,644
-58,104
| -27% | -$3.12M |
|
105
PAR Technology
PAR
$2B
| $7.97M | 0.24% |
305,588
+125,588
| +70% | +$3.27M |
|
106
OSI Systems
OSIS
$3.92B
| $7.75M | 0.24% |
97,426
-16,223
| -14% | -$1.29M |
|
107
Intellia Therapeutics
NTLA
$1.26B
| $7.59M | 0.23% |
217,623
+66,788
| +44% | +$2.33M |
|
108
Kiniksa Pharmaceuticals
KNSA
$2.63B
| $7.55M | 0.23% |
504,193
-48,157
| -9% | -$721K |
|
109
Onto Innovation
ONTO
$5.03B
| $7.5M | 0.23% |
110,088
+17,381
| +19% | +$1.18M |
|
|
CSSE
110
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
| $7.06M | 0.22% |
1,379,179
+91,214
| +7% | +$467K |
|
111
Qualys
QLYS
$4.9B
| $6.96M | 0.21% |
62,039
+10,844
| +21% | +$1.22M |
|
112
EPAM Systems
EPAM
$9.69B
| $6.86M | 0.21% |
20,937
+2,431
| +13% | +$797K |
|
113
TechTarget
TTGT
$395M
| $6.82M | 0.21% |
154,873
+26,525
| +21% | +$1.17M |
|
|
RVNC
114
DELISTED
Revance Therapeutics, Inc.
RVNC
| $6.43M | 0.2% |
348,064
+103,147
| +42% | +$1.9M |
|
115
Beam Therapeutics
BEAM
$1.9B
| $6.41M | 0.2% |
163,790
+53,355
| +48% | +$2.09M |
|
116
AXT Inc
AXTI
$142M
| $6.28M | 0.19% |
1,433,444
+417,483
| +41% | +$1.83M |
|
117
Kinsale Capital Group
KNSL
$10.5B
| $6.18M | 0.19% |
23,645
-2,718
| -10% | -$711K |
|
118
CorVel
CRVL
$4.47B
| $6.17M | 0.19% |
127,410
+13,533
| +12% | +$656K |
|
119
Fate Therapeutics
FATE
$115M
| $6.08M | 0.19% |
602,153
+275,734
| +84% | +$2.78M |
|
120
Zymeworks
ZYME
$1.07B
| $5.8M | 0.18% |
738,448
+150,640
| +26% | +$1.18M |
|
121
Mesa Laboratories
MLAB
$338M
| $5.63M | 0.17% |
33,894
-1,001
| -3% | -$166K |
|
122
Silicon Laboratories
SLAB
$4.3B
| $5.61M | 0.17% |
41,370
+7,895
| +24% | +$1.07M |
|
123
Grocery Outlet
GO
$1.78B
| $5.56M | 0.17% |
190,317
+67,459
| +55% | +$1.97M |
|
124
Pacific Biosciences
PACB
$378M
| $5.54M | 0.17% |
677,158
+102,969
| +18% | +$842K |
|
125
American Well
AMWL
$112M
| $5.36M | 0.16% |
94,724
+11,247
| +13% | +$637K |
|